Development Process and Key Milestones
■ In 1997, Taizhou Xianyuan Medical and Health Products Co., Ltd, the predecessor of Starry Pharm, was established.
■ In 2000, Mr. Hu Jinsheng and Mr. Wu Jinwei worked together and changed its name to Zhejiang Taizhou Starry Pharmaceutical Chemical Co., Ltd., and levofloxacin hydrochloride, its first left oxygen product, was successfully developed.
■ In 2003, with the approval of Zhejiang Provincial Drug Administration, the company set up a pharmaceutical factory -- Zhejiang Starry Pharmaceutical Co., Ltd. in Xianju Sanqiao
■ In 2004, iohexol products passed GMP certification and obtained the "Drug Production License".
■ In 2005, the company was rated as a high-tech enterprise.
■ In 2006, it was changed to a Sino-foreign joint venture. In November of the same year, the company took 120 mu of land from Xianju County's modern industrial agglomeration area and broke ground to build a new factory building.
■ In 2008, the company moved its administrative center to the new factory area in Yangfu.
■ In 2011, the shareholding system reform was completed and Starry established.
■ Jiangxi Starry Pharmaceutical Co., Ltd. was established.
■ In 2012, Shanghai Starry Pharmaceutical Co., Ltd. was established.
■ In 2015, Shanghai Jianhe Pharmaceutical Technology Co., Ltd was established.
■ Zhejiang Taizhou Haishen Pharmaceutical Co., Ltd. was acquired.